Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex)

alkiviadis.1961 shared this article with you from Inoreader Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex) Via BMJ Case Reports Last 6 Issues A 59-year-old man with diabetic macular oedema was treated with a dexamethasone intravitreal implant (Ozurdex) to his right eye. Immediately after injection, the implant was noted to have extruded into the perilimbal subconjunctival space. The remnants of the implant were expeditiously removed the following day to avoid corneal decompensation and permanent corneal oedema. Endothelial decompensation secondary to the migration of dexamethasone implants into the subconjunctiva l space or anterior chamber is a recognised complication of Ozurdex injection. The patient recovered well postoperatively with no further complications. He was planned for a new Ozurdex implant 1 month later. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.